Abstract:BACKGROUND: To date, the use of bone marrow-derived mesenchymal stem cells (MSCs) for the treatment of Parkinson's disease have solely focused on in vivo animal models. Because of the number of influencing factors, it has been difficult to determine a consistent outcome.OBJECTIVE: To establish an injury model in brain slices of substantia nigra and striaturn using 1-methyl-4-phonylpytidinium ion (MPP), and to investigate the effect of MSCs on dopaminergic neurons following MPP+ induced damage.DESIGN, TIME AND SETTING: An in vitro, randomized, controlled, animal experiment using immunohistochemistry was performed at the Laboratory of the Department of Anatomy, Fudan University between January 2004 and December 2006.MATERIALS: Primary MSC cultures were obtained from femurs and tibias of adult Sprague Dawley rats. Organotypic brain slices were isolated from substantia nigra and striaturn of 1-day-old Sprague Dawley rat pups. Monoclonal antibodies for tyrosine hydroxylase (TH, 1:5 000) were from Santa Cruz (USA); goat anti-rabbit IgG antibodies labeled with FITC were from Boster Company (China).METHODS: Organotypic brain slices were cultured for 5 days in whole culture medium supplemented with 50% DMEM, 25% equine serum, and 25% Tyrode's balanced salt solution. The medium was supplemented with 5 mu g/mLAra-C, and the culture was continued for an additional 5 days. The undergrowth of brain slices was discarded at day 10. Eugonic brain slices were cultured with basal media for an additional 7 days. The brain slices were divided into three groups: control, MPP+ exposure, and co-culture. For the MPP+ group, MPP+ (30 mu mol/L) was added to the media at day 17 and brain slices were cultured for 4 days, followed by control media. For the co-culture group, the MPP+ injured brain slices were placed over MSCs in the well and were further cultured for 7 days. MAINOUTCOME MEASURES: After 28 days in culture, neurite outgrowth was examined in the brain slices under phase-contrast microscopy. The percent of area containing dead cells in each brain slice was calculated with the help of propidium iodide fluorescence. Brain slices were stained with antibodies for TH to indicate the presence of dopaminergic neurons. Transmission electron microscopy was applied to determine the effect of MSCs on neuronal ultrastructure.RESULTS: Massive cell death and neurite breakage was observed in the MPP+ group. In addition, TH expression was significantly reduced, compared to the control group (P < 0.01). After 7 days in culture With MSCs, the co-culture group presented with less cell damage and reduced neurite breakage, and TH expression was increased. However, these changes were not significantly different from the MPP+ group (P < 0.01). Electron microscopy revealed reduced ultrastructural injury to cells in the brain slices. However, vacuoles were present in cells, With some autophagic vacuoles.CONCLUSION: Bone marrow-derived MSCs can promote survival of dopaminergic neurons following MPP+-induced neurotoxicity in co-cultures with substantia nigra and striaturn brain slices.

EFFECT OF BONE MARROW STROMAL CELLS ON PC12 APOPTOSIS INDUCED BY 1-METHYL-4-PHENYLPYRIDINE

Secretory Factors of Bone Marrow Stromal Cells Promoting Differentiation and Survival of PC12 Cells

Protective Paracrine Effect of Mesenchymal Stem Cells on Cardiomyocytes

Protective Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Dopaminergic Neurons Against 1-Methyl-4-phenylpyridinium Ion-Induced Neurotoxicity in Rat Brain Slices

Effect of Bone Marrow Mesenchymal Stem Cells on Spleen T Lymphocyte Functions in apoE~(-/-) Mice

Effect of Bone Marrow Stromal Cells on the Anoxia Cardiomyocytes in Vitro

Effects of Bone Marrow Mescenchymal Stem Cells Conditioned-Medium on Cortical Neuronal Apoptosis Induced by Hypoxia-Reoxygenation in vitro in Rats

The Protective Effect of Bone Marrow Mesenchymal Stem Cells by Anoxic Preconditioning on Diabetic Cardiomyopathy

Prolyl Hydroxylase Inhibitor Dimethyloxalylglycine Enhances Mesenchymal Stem Cell Survival

Effect of rat endothelial progenitor cell on proliferation and apoptosis of bone marrow mesenchymal stem cell

Influences on expression of tyrosine hydroxylase in rats with Parkinson's disease treated by bone mesenchymal stem cell

Mitochondrial calcium uniporter-mediated inhibition of 1-methyl-4-phenylpyridinium ions neurotoxicity in PC12 cells

Potential molecular mechanisms mediating the protective effects of tetrahydroxystilbene glucoside on MPP + -induced PC12 cell apoptosis

Effects of hypoxia preconditioning on the proliferation, apoptosis and necrosis of bone marrow derived mesenchymal stem cells (BMSCs)

Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model

[MPP+ Decreased BDNF Expression in PC12 Cells].

Protective Effect of Erythropoietin Against 1-Methyl-4-phenylpyridinium-induced Neurodegenaration in PC12 Cells

Genetic research of mouse bone marrow mesenchymal stem cells subsets SCA-1+ / CD45+ / CD31+ itself anti-apoptotic ability

Tetramethylpyrazine induces the release of BDNF from BM‐MSCs through activation of the PI3K/AKT/CREB pathway

Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha

Bone Marrow-Derived Mesenchymal Stem Cell-Derived Exosomes Containing Gli1 Alleviate Microglial Activation and Neuronal Apoptosis In Vitro and in a Mouse Parkinson Disease Model by Direct Inhibition of Sp1 Signaling